High-resolution imaging of organic pharmaceutical crystals by transmission electron microscopy and scanning moiré fringes.


Journal

Journal of microscopy
ISSN: 1365-2818
Titre abrégé: J Microsc
Pays: England
ID NLM: 0204522

Informations de publication

Date de publication:
09 2020
Historique:
received: 02 10 2019
revised: 16 01 2020
accepted: 23 01 2020
pubmed: 28 1 2020
medline: 27 8 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

Formulation processing of organic crystalline compounds can have a significant effect on drug properties, such as dissolution rate or tablet strength/hardness. Transmission electron microscopy (TEM) has the potential to resolve the atomic lattice of these crystalline compounds and, for example, identify the defect density on a particular crystal face, provided that the sensitivity of these crystals to irradiation by high-energy electrons can be overcome. Here, we acquire high-resolution (HR) lattice images of the compound furosemide using two different methods: low-dose HRTEM and bright-field (BF) scanning TEM (STEM) scanning moiré fringes (SMFs). Before acquiring HRTEM images of furosemide, a model system of crocidolite (asbestos) was used to determine the electron flux/fluence limits of low-dose HR imaging for our scintillator-based, complementary metal-oxide semiconductor (CMOS) electron camera by testing a variety of electron flux and total electron fluence regimes. An electron flux of 10 e

Identifiants

pubmed: 31985063
doi: 10.1111/jmi.12866
pmc: PMC8611800
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-206

Informations de copyright

© 2020 The Authors. Journal of Microscopy published by John Wiley & Sons Ltd on behalf of Royal Microscopical Society.

Références

Langmuir. 2016 Jul 26;32(29):7411-9
pubmed: 27419264
J Pharm Sci. 2010 Sep;99(9):4072-83
pubmed: 20665849
Microsc Res Tech. 2000 May 1;49(3):269-80
pubmed: 10816267
Mol Pharm. 2018 Nov 5;15(11):5114-5123
pubmed: 30212216
Science. 2018 Feb 9;359(6376):675-679
pubmed: 29348363
Microscopy (Oxf). 2017 Jun 1;66(3):217-221
pubmed: 28339765
Nanotechnology. 2018 Apr 20;29(16):165704
pubmed: 29485106
Micron. 2004;35(6):399-409
pubmed: 15120123
Micron. 2019 May;120:1-9
pubmed: 30739878
Science. 1985 Aug 2;229(4712):461-2
pubmed: 4012326
Mol Pharm. 2015 Mar 2;12(3):983-90
pubmed: 25699402
Pharm Res. 2006 Apr;23(4):813-20
pubmed: 16463008
Ultramicroscopy. 2010 Feb;110(3):229-33
pubmed: 20006440
J Pharm Sci. 2005 Jun;94(6):1321-35
pubmed: 15858842
Ultramicroscopy. 2014 Oct;145:85-93
pubmed: 24679438
J Pharm Sci. 2015 Aug;104(8):2401-13
pubmed: 26096636
Ultramicroscopy. 2019 Aug;203:125-131
pubmed: 30773415

Auteurs

M S'ari (M)

School of Chemical and Process Engineering, University of Leeds, Leeds, UK.

N Koniuch (N)

School of Chemical and Process Engineering, University of Leeds, Leeds, UK.

R Brydson (R)

School of Chemical and Process Engineering, University of Leeds, Leeds, UK.

N Hondow (N)

School of Chemical and Process Engineering, University of Leeds, Leeds, UK.

A Brown (A)

School of Chemical and Process Engineering, University of Leeds, Leeds, UK.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Animals Rumen Methane Fermentation Cannabis
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines

Classifications MeSH